Replies to post #9371 on Cytodyn Inc (CYDY)

[Northstar42]

Agree that Nader would not apply for BTD unless it was a near certainty.

[Saltz]

BTD would seem to be a certainty and we could have that before CROI. It seems the majority on this board are in agreement that the P3 Adjunct Combo Trial results are going to garner FDA Approval for our first label. Most of the debate has surrounded the probability of a successful P3 Mono Trial. The consensus is we don't make that far before a buyout and P3 Mono approval is a long shot-I don't agree. The people in the know tell me BP does not move until they have to. So the question is, is Adjunct Combo approval enough to move BP and what is the price tag with the P3 Mono in process. That seems to be the poker game that is in the making.